CCNE1 and breast carcinoma: Given the contributing role of cyclin E in mammary gland hyperplasia and tumourigenesis [38,39], it is conceivable that the deregulation of cyclin E as a result of NHERF1 loss contributes to the breast cancer initiation or progression.